Howard Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253K Sell
2,969
-2,919
-50% -$260K ﹤0.01% 296
2025
Q4
$465K Buy
5,888
+31
+0.5% +$2.43K 0.01% 320
2025
Q3
$468K Buy
5,857
+150
+3% +$12.8K 0.01% 309
2025
Q2
$519K Buy
5,707
+881
+18% +$80.4K 0.01% 285
2025
Q1
$452K Sell
4,826
-743
-13% -$66.5K 0.01% 270
2024
Q4
$506K Buy
5,569
+250
+5% +$23.9K 0.01% 287
2024
Q3
$552K Buy
+5,319
New +$542K 0.01% 265

Other funds holding CL

Howard Capital Management's CL Position: Q1 2026 in Review

Howard Capital Management reduced its Colgate-Palmolive (CL) stake by 50% in Q1 2026, selling an estimated $260K and leaving 2,969 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Howard Capital Management first reported a position in CL in Q3 2024 and has held it in 7 quarters since. The position peaked at $552K in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Howard Capital Management held 2,969 shares of Colgate-Palmolive worth $253K as of Q1 2026.
  • Howard Capital Management sold 2,919 Colgate-Palmolive shares in Q1 2026, an estimated $260K.
  • Colgate-Palmolive made up ﹤0.01% of Howard Capital Management's portfolio in Q1 2026, its #296 holding.
  • Howard Capital Management first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 7 quarters since.
  • Howard Capital Management's Colgate-Palmolive position peaked at $552K in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Howard Capital Management's 13F filing for Q1 2026, filed 5 May 2026.